Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects
Open Access
- 15 September 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 198 (6) , 800-807
- https://doi.org/10.1086/591141
Abstract
Background. The prevalence and clinical implications of naturally occurring variants that are resistant to hepatitis C virus (HCV) protease inhibitorKeywords
This publication has 35 references indexed in Scilit:
- New therapies for hepatitis CHepatology, 2007
- Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034Antiviral Research, 2006
- In vitro selected Con1 subgenomic replicons resistant to 2′-C-Methyl-Cytidine or to R1479 show lack of cross resistanceVirology, 2006
- Mutations Conferring Resistance to SCH6, a Novel Hepatitis C Virus NS3/4A Protease InhibitorJournal of Biological Chemistry, 2006
- Binding Site Characterization and Resistance to a Class of Non-nucleoside Inhibitors of the Hepatitis C Virus NS5B PolymeraseJournal of Biological Chemistry, 2005
- Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In VitroAntimicrobial Agents and Chemotherapy, 2005
- Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication AssayAntimicrobial Agents and Chemotherapy, 2005
- Genetic diversity and evolution of hepatitis C virus – 15 years onJournal of General Virology, 2004
- Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymeraseJournal of Virology, 2003
- Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in VitroJournal of Biological Chemistry, 2003